Reporting Adverse Drug Reactions and Adverse Events Following Immunisation

  • Please report ALL suspected Adverse Drug Reactions (ADRs) (including those for traditional products) and Adverse Events Following Immunisation (AEFIs) to the National Centre for Adverse Drug Reactions Monitoring.
  • Do not hesitate to report if some details are not known.
  • The identities of Reporter, Patient and Institution will remain confidential.
  • Kindly report ADR/AEFI through only ONE channel:
    • PhIS version 1.7 & above*, OR
    • webform, OR
    • manual submission by mail/fax/email.

Repeated submission using multiple channels is NOT necessary.

*Note: If your facility is equipped with PhIS version 1.7 & above, your PhIS ADR report will be automatically pushed to NPRA. For any enquiries related to PhIS reporting, please contact PhIS helpdesk.

IMPORTANT NOTES FOR ONLINE REPORTING:

  • Please use 'Google Chrome' as your web browser.
  • Mandatory fields (marked with *): Please fill in all mandatory fields in order to successfully submit the form.
  • Non-mandatory fields: Please give as much information as you can. If the relevant information is not known, kindly leave the field(s) blank.
  • Numeric fields: Please fill in whole numbers only (no decimal points) [Refer user guide for details]
  • Please read this user guide BEFORE proceeding to complete the online reporting form.

ADR/AEFI Web Form

Manual ADR/AEFI Reporting Form - PDF

*to submit by post, email or fax

Guide for ADR Reporters

  • Definitions
  • Checklist for ADR Reporters
  • Submitting samples for Laboratory Testing of Suspected Adulterated Products
  • VigiAccess: A public gateway to the WHO ADR Database
  • ADR Reports on AntiTB drugs

Cutaneous Adverse Drug Reaction (ADR) Classification

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Newsletter Subsription

Site Last Modified

  • Last Modified: Friday 14 December 2018, 08:46:08.
© Copyright 2018 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

MOH Pharmacy Staff